Recent research has revealed that a loss-of-function mutation in SPRED3 is responsible for activating the Ras/Raf/MAPK pathway in non-small cell lung cancer (NSCLC) cells20. The gene discussed is SPRED3; the disease is non-small cell lung carcinoma.